This creates a downward spiral: less protein leads to more muscle loss, which lowers metabolic rate, which makes weight loss harder, which increases frustration
A drop of medicine on the needle tip is normal and will not affect your dose
Sensitivity landmark analyses stratified by timeframe of semaglutide initiation Given that semaglutide was initially approved for type 2 diabetes, with initial obesity approval in 2021, it is possible that inclusion of non-diabetic patients could introduce indication bias in the previously described analyses, as non-diabetic patients enrolled before 2021 likely represent off-label use and may differ systematically from those treated after approval
These cases will likely be representative of the litigation as a whole, meaning many of these same factors would be at play in a majority of claims
Any combination protocol should be discussed with a knowledgeable healthcare provider to ensure safety and appropriate dosing
Severe or persistent vomiting, severe abdominal pain, fainting, dehydration, confusion, or symptoms of low blood sugar need prompt medical assessment, especially after a possible dosing error